These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 28545481)

  • 1. Therapeutic strategies to address neuronal nitric oxide synthase deficiency and the loss of nitric oxide bioavailability in Duchenne Muscular Dystrophy.
    Timpani CA; Hayes A; Rybalka E
    Orphanet J Rare Dis; 2017 May; 12(1):100. PubMed ID: 28545481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy.
    Sander M; Chavoshan B; Harris SA; Iannaccone ST; Stull JT; Thomas GD; Victor RG
    Proc Natl Acad Sci U S A; 2000 Dec; 97(25):13818-23. PubMed ID: 11087833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide synthase deficiency and the pathophysiology of muscular dystrophy.
    Tidball JG; Wehling-Henricks M
    J Physiol; 2014 Nov; 592(21):4627-38. PubMed ID: 25194047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy.
    Bia BL; Cassidy PJ; Young ME; Rafael JA; Leighton B; Davies KE; Radda GK; Clarke K
    J Mol Cell Cardiol; 1999 Oct; 31(10):1857-62. PubMed ID: 10525423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide and l-arginine cause an accumulation of utrophin at the sarcolemma: a possible compensation for dystrophin loss in Duchenne muscular dystrophy.
    Chaubourt E; Fossier P; Baux G; Leprince C; Israël M; De La Porte S
    Neurobiol Dis; 1999 Dec; 6(6):499-507. PubMed ID: 10600405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved Muscle Function in Duchenne Muscular Dystrophy through L-Arginine and Metformin: An Investigator-Initiated, Open-Label, Single-Center, Proof-Of-Concept-Study.
    Hafner P; Bonati U; Erne B; Schmid M; Rubino D; Pohlman U; Peters T; Rutz E; Frank S; Neuhaus C; Deuster S; Gloor M; Bieri O; Fischmann A; Sinnreich M; Gueven N; Fischer D
    PLoS One; 2016; 11(1):e0147634. PubMed ID: 26799743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The serum nitric oxide levels in patients with Duchenne muscular dystrophy.
    Gücüyener K; Ergenekon E; Erbas D; Pinarli G; Serdaroğlu A
    Brain Dev; 2000 May; 22(3):181-3. PubMed ID: 10814901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenic impairment of the vascular endothelium: a novel mechanism and potential therapeutic target in muscular dystrophy.
    Palladino M; Gatto I; Neri V; Straino S; Smith RC; Silver M; Gaetani E; Marcantoni M; Giarretta I; Stigliano E; Capogrossi M; Hlatky L; Landolfi R; Pola R
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2867-76. PubMed ID: 24072696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with a nitric oxide-donating NSAID alleviates functional muscle ischemia in the mouse model of Duchenne muscular dystrophy.
    Thomas GD; Ye J; De Nardi C; Monopoli A; Ongini E; Victor RG
    PLoS One; 2012; 7(11):e49350. PubMed ID: 23139842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the therapeutic utility of phosphodiesterase 5A inhibition in the mdx mouse model of duchenne muscular dystrophy.
    Percival JM; Adamo CM; Beavo JA; Froehner SC
    Handb Exp Pharmacol; 2011; (204):323-44. PubMed ID: 21695647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibre-related nitric oxide synthase (NOS) in Duchenne muscular dystrophy.
    Punkt K; Schering S; Fritzsche M; Asmussen G; Minin EA; Samoilova VE; Müller FU; Schmitz W; Hasselblatt M; Paulus W; Müller-Werdan U; Slezak J; Koehler G; Boecker W; Buchwalow IB
    Acta Histochem; 2007; 109(3):228-36. PubMed ID: 17313973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice.
    Wehling M; Spencer MJ; Tidball JG
    J Cell Biol; 2001 Oct; 155(1):123-31. PubMed ID: 11581289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide-dependent attenuation of noradrenaline-induced vasoconstriction is impaired in the canine model of Duchenne muscular dystrophy.
    Kodippili K; Hakim CH; Yang HT; Pan X; Yang NN; Laughlin MH; Terjung RL; Duan D
    J Physiol; 2018 Nov; 596(21):5199-5216. PubMed ID: 30152022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Airway nitric oxide in Duchenne muscular dystrophy.
    Straub V; Ratjen F; Amthor H; Voit T; Grasemann H
    J Pediatr; 2002 Jul; 141(1):132-4. PubMed ID: 12091865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Association between dystrophin and neuronal nitric oxide synthase in muscles of progressive muscular dystrophy].
    Wang S; Shen D
    Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):155-7. PubMed ID: 11953148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dystrophin Threshold Level Necessary for Normalization of Neuronal Nitric Oxide Synthase, Inducible Nitric Oxide Synthase, and Ryanodine Receptor-Calcium Release Channel Type 1 Nitrosylation in Golden Retriever Muscular Dystrophy Dystrophinopathy.
    Gentil C; Le Guiner C; Falcone S; Hogrel JY; Peccate C; Lorain S; Benkhelifa-Ziyyat S; Guigand L; Montus M; Servais L; Voit T; Piétri-Rouxel F
    Hum Gene Ther; 2016 Sep; 27(9):712-26. PubMed ID: 27279388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nitrate ester of sedative alkyl alcohol improves muscle function and structure in a murine model of Duchenne muscular dystrophy.
    Wang G; Lu Q
    Mol Pharm; 2013 Oct; 10(10):3862-70. PubMed ID: 23924275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Just say NO to muscle degeneration?
    Froehner SC
    Trends Mol Med; 2002 Feb; 8(2):51-3. PubMed ID: 11815264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuronal nitric oxide synthase (nNOS) splice variant function: Insights into nitric oxide signaling from skeletal muscle.
    Balke JE; Zhang L; Percival JM
    Nitric Oxide; 2019 Jan; 82():35-47. PubMed ID: 30503614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy.
    Villalta SA; Nguyen HX; Deng B; Gotoh T; Tidball JG
    Hum Mol Genet; 2009 Feb; 18(3):482-96. PubMed ID: 18996917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.